🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Peripheral stem cell transplantation may be able to replace immu...
Status
Terminated
Location
Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Start Date
1999-09
Trial ID
NCT00005787
To determine the safety, tolerability and maximum tolerated dose of SDZ ILE...
Status
Completed
Location
New England Deaconess Hosp
Start Date
TBD
Trial ID
NCT00002258
Treatments Being Tested
This phase I/II trial studies the side effects, best dose, and effect of ta...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2022-03-04
Trial ID
NCT05038592
Treatments Being Tested
This observational study assessed whether measurements of certain pro-infla...
Status
Completed
Location
University of Alabama
Start Date
1999-07
Trial ID
NCT01035697
RATIONALE: Peripheral stem cell transplantation may be able to replace immu...
Status
Completed
Location
Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Start Date
1999-11
Trial ID
NCT00006225
This is a phase I study to determine the maximal tolerated dose of IL-3 giv...
Status
Completed
Location
National Cancer Institute (NCI)
Start Date
1991-05
Trial ID
NCT00001269
Treatments Being Tested
This phase Ib/II trial tests the safety of tagraxofusp when given with or w...
Status
Withdrawn
Location
Habtemariam,Bruck
Start Date
2024-08-03
Trial ID
NCT05720988
Treatments Being Tested
This phase II trial studies how well venetoclax, SL-401, and chemotherapy w...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2020-05-29
Trial ID
NCT04216524
RATIONALE: Combinations of biological substances in DT388IL3 fusion protein...
Status
Completed
Location
UT Southwestern Medical Center
Start Date
2013-05
Trial ID
NCT00397579
Treatments Being Tested
This phase Ib trial tests the safety, side effects, best dose and effective...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2025-01-28
Trial ID
NCT06498973